Video

Connecting the Dots

Undescribed image
Podcast

Looking forward to 2022: MedTech Europe CEO’s reflections on the upcoming year

Undescribed image
Cardiovascular

An EU Action Plan for Better Cardiovascular Health

Undescribed image
Facts & Figures

The Facts and Figures 2021: check the latest industry data

Undescribed image
COVID-19

COVID-19 MedTech Europe Information Hub

  • 01
  • 02
  • 03
  • 04
  • 05

/ 05

Latest updates

Resource library COVID19

MedTech Europe’s recommendations on testing as Europe enters the winter season

MedTech Europe offers four recommendation on testing as Europe enters the winter season in order to continue monitoring the development of the COVID-19 pandemic while quickly identifying and distinguishing other respiratory pathogens and disease outbreaks.

Posted on 29.10.2021

Read more More resources
Resource library Access to Medical Technology Digital Health The Value of Medical Technology Value-Based Procurement

Recognising the value of digital health apps: An assessment of five European healthcare systems

Europe’s health systems are under pressure. Demographic changes, rising incidences of chronic disease, and a shortage of healthcare professionals undermine their ability to deliver care. Digital health technologies (DHTs) have the potential to make healthcare safer, better and more efficient. Yet levels of their deployment in Europe’s healthcare systems remain low. An overarching barrier to the deployment of DHTs is the lack of appropriate mechanisms for funding and reimbursement. In a new set of papers that focus on digital health, we seek to understand and document these barriers in Europe’s healthcare systems and propose ways in which these barriers can be mitigated or removed. The first paper focuses on the Funding and Reimbursement Mechanisms for Digital Health Technologies in Europe”. MedTech Europe, as the voice of Europe’s medical technologies industry, calls on national and regional policymakers and payers to recognise the value and incentivise the use of DHTs in Europe’s healthcare systems, by setting up clear frameworks for reimbursement and funding pathways that will enable their uptake and use in Europe’s healthcare systems.

Posted on 15.11.2021

Read more More resources

A life of adventure after stroke

When Paul McLean suffered a severe stroke at the age of 40 his chances didn’t look good. Thanks to an innovative procedure enabled by medical technology, Paul is now embracing a life filled with adventure and is enjoying watching his young son grow up.

Undescribed image

Testing Times: we have the tools to meet next healthcare challenges

As Europe enters the fourth wave of COVID-19 and countries start to impose lockdown restrictions, we must not forget that we have the tools to tackle this.

Undescribed image

About us

MedTech Europe is the European trade association representing the medical technology industries, from diagnosis to cure.

We represent Diagnostics and Medical Devices manufacturers operating in Europe. There are more than 500,000 products, services and solutions currently made available by the medical technology industry. These range from bandages, blood tests and hearing aids to cancer screening tests, pacemakers and glucose monitors.

Our sector employs more than 730,000 people. There are more than 32,000 medical technology companies in Europe, of which 95% are SMEs.

Undescribed image

What we work on

Interactions with the Medical Community

Interactions with the Medical Community

The medical technology industry is expected to find new ways to keep us healthy, and to do so in a responsible manner. MedTech Europe and its members are committed to a high level of ethical business practices and have put in place strict guidelines to advise medical technology manufacturers on how to collaborate ethically with healthcare professionals (HCPs).

Interactions with the Medical Community Picture

Brexit

Brexit

Brexit is a critical topic for the medical technology industry which has developed highly complex ties between the United Kingdom (UK) and the rest of the EU. Medical technologies are often moved between different EU countries during their production lifecycle and their clinical use. Crucially, up to 30% of our industry’s products have been authorised via UK Notified Bodies (CE marking) and could lose such authorisation overnight in the case of a “cliff edge” Brexit. MedTech Europe is tracking developments closely and has produced a position paper and other relevant documents to help medtech companies to navigate Brexit.

Brexit Picture

Access to Medical Technology

Access to Medical Technology

Medical technologies have the potential to save and improve lives, to inform citizens on the state of their health and to guide healthcare delivery.

Access to medical technology picture

New Medical Technology Regulations

New Medical Technology Regulations

Medical technologies are tightly regulated in the European Union. Before a medical technology can be legally placed on the EU market, a manufacturer must comply with the requirements of all applicable EU legislation and affix a CE mark to their device.

New EU Regulations governing medical devices (MD) and in vitro diagnostic (IVD) were published in May 2017. MedTech Europe is working with our members and the authorities to support companies in complying with the new legislation by the end of the transition periods – 2021 for MDs and 2022 for IVDs.

The European Neighbourhood

COVID-19 Information Hub

COVID-19 Information Hub

As the spread of the coronavirus COVID-19 continues to impact the health of people and the economy of countries around the world, the medical technology industry is working to support all ongoing efforts against this pandemic.

Undescribed image

Homecare & Community Care

Homecare & Community Care

The MedTech industry develops products that facilitate the delivery of health services in the community care setting and in people's homes. These technologies save lives, are convenient for patients and make efficient use of healthcare resources.

Homecare and community care

Environmental and Social Sustainability

Environmental and Social Sustainability

In addition to the medical technology sector’s core goal of saving lives and improving health, environmental and social considerations are an integral part of our industry’s operations. We acknowledge that preserving a healthy environment and building socially responsible value chains are essential in keeping human beings in good health. Our industry needs to be at the forefront of addressing challenges related to sustainable healthcare.

Environmental sustainability picture

Market Data

Market Data

Information is power. Medical technology companies need to stay on top of the latest trends impacting their business. Informed decisions require up-to-date market intelligence from a trusted service.

Business stats displayed as graph and chart on a futuristic interface - Business concept

Digital Health

Digital Health

Medical technologies generate information and data that are critical for the prevention, diagnosis, treatment, monitoring and management of health and lifestyle. More and more of this data is now digitised; it can be stored and accessed on electronic health records and personal devices, shared among patients and healthcare professionals, and aggregated and processed with data advanced analytics
MedTech Europe works with policymakers and relevant stakeholders to realise the potential of data-driven healthcare. Together we focus on legal and regulatory issues (privacy, safety), technology (cybersecurity, interoperability), the business case (incentives, reimbursement), and emerging technologies (precision medicine, artificial intelligence).

Digital Picture

International

International

MedTech Europe engages with global agencies, decision-makers and stakeholders on key international issues facing medical technology companies.

International Picture

Research and Innovation

Research and Innovation

Research & Innovation (R&I) is the lifeblood of Europe’s medical technology sector. Industry investment in R&I delivers life-enhancing devices, diagnostics and digital solutions. EU support for R&I offers valuable opportunities for academia and industry to generate new knowledge and use it to tackle the biggest challenges facing our societies. The quest for tomorrow’s healthcare innovations demands new, broad partnerships. R&I is most impactful when it is based on collaboration. MedTech Europe is committed to working with others in the public and private sectors to find shared solutions to our common challenges.

Research and Innovation

Ophthalmology

Ophthalmology

Vision loss can have a profound impact on those affected, resulting in lost independence and significantly limiting daily activities. Ageing increases the risk of eye diseases that can lead to visual impairment. The MedTech industry develops products that reduce the burden of eye disease on individuals, families and the wider economy. These innovations add enormous value to European society.

concept vision testing. child girl with eyeglasses

Antimicrobial Resistance (AMR) and Healthcare Associated Infections (HAIS)

Antimicrobial Resistance (AMR) and Healthcare Associated Infections (HAIS)

Antimicrobial Resistance (AMR) and Healthcare Associated Infections (HAI) are among the biggest global public health challenges of our time. These infections cause significant morbidity and mortality, put pressure on health systems, and incur rising direct and indirect costs.
Medical technologies can help to address these problems by preventing, detecting, monitoring and managing infections and resistance.

Pathogen growth on selective media.

Cardiovascular

Cardiovascular

Cardiovascular diseases can impact millions of people of all ages. Diseases of the heart and circulatory system are the leading cause of death in Europe and a major cause of disability.

The medical technology industry provides high-quality solutions to the burden of cardiovascular diseases on individuals, families and the wider society. These innovations, which span the full spectrum of patient care from diagnosis to cure, save lives and add tremendous value to European society.

Cardiovascular Picture

Orthopaedic

Orthopaedic

Orthopaedics is the medical specialty that focuses on injuries and diseases of the human body's musculoskeletal system. This complex system includes your bones, joints, ligaments, tendons, muscles, and nerves and allows you to move, work, and be active.

The MedTech industry develops products that reduce the burden of musculoskeletal diseases on individuals, families and the wider economy. These innovations improve quality of life and add enormous value to European society.

Image of concentrated disabled athlete woman

Diabetes

Diabetes

1 in 11 adults around the world have diabetes. That’s about 60 million people across Europe, equivalent to the total Italian population. This number increases significantly every year. If current trends continue, diabetes will be the number one health threat in the coming years.

The European Diabetes Sector Group aims to reverse this trend by taking meaningful collective action to help avoid the diabetes pandemic where possible, and when diagnosis occurs to put people at the centre of care and give them back a full and fear-free life.

Diabetes Picture